[1] Petermann-Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and Meta-analysis[J]. J Cachexia Sarcopenia Muscle. 2022, 13: 86-99. [2] Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age and Ageing, 2019, 48: 16-31. [3] Fanciulli A, Wenning GK. Multiple-system atrophy[J]. N Engl J Med, 2015, 372: 249-263. [4] Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study[J]. Lancet, 1999, 354: 1771-1775. [5] Levin J, Kurz A, Arzberger T, et al. The differential diagnosis and treatment of atypical Parkinsonism[J]. Dtsch Arztebl Int, 2016, 113: 61-69. [6] Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson's disease[J]. Mov Disord, 2009, 24: 1881-1892. [7] Hart A, Cordova-Rivera L, Barker F, et al. The preva-lence of sarcopenia in Parkinson's disease and related disorders- a systematic review[J]. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2023, 44: 4205-4217. [8] da Luz MCL, Bezerra GKA, Asano AGC, et al. Determinant factors of sarcopenia in individuals with Parkinson's disease[J]. Neurol Sci, 2021, 42: 979-985. [9] Lima DP, de Almeida SB, Bonfadini J de C, et al. Clinical correlates of sarcopenia and falls in Parkinson's disease[J]. PLoS One, 2020, 15: e0227238.doi:10.1371/journal.pone.0227238. [10] Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy[J]. Neurology, 2008, 71: 670-676. [11] Shinar D, Gross CR, Bronstein KS, et al. Reliability of the activities of daily living scale and its use in telephone interview[J]. Arch Phys Med Rehabil, 1987, 68: 723-728. [12] Cai Y, Feng F, Wei Q, et al. Sarcopenia in patients with Parkinson's disease: a systematic review and Meta-analysis[J]. Front Neurol, 2021, 12: 598035.doi:10.33891/fneur.2021.598035. [13] Barichella M, Pinelli G, Iorio L, et al. Sarcopenia and dynapenia in patients with Parkinsonism[J]. J Am Med Dir Assoc, 2016, 17: 640-646. [14] Xie D, Huang H, Zhao Q, et al. Prevalence and associated factors of frailty and sarcopenia in multiple system atrophy and progressive supranuclear palsy: a cross-sectional study[J]. Neurol Sci, 2022, 43: 6329-6337. [15] Gill TM, Gahbauer EA, Allore HG, et al. Transitions between frailty states among community-living older persons[J]. Arch Intern Med, 2006, 166: 418-423. [16] Barichella M, Cereda E, Pinelli G, et al. Muscle-targeted nutritional support for rehabilitation in patients with Parkinsonian syndrome[J]. Neurology, 2019, 93: e485-e496. |